Above information suggests that RAS/ERK pathway can maintain or regulate cancer stemness in colon cancer, which is particularly true in K-RasG13D mutated colon cancer where the mutation more specifically activated on ERK. Here, MAPK1 is linked to malignant colon neoplasm.